Search Results

There are 90795 results for: content related to: Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

  1. HBV DNA suppression in HBeAg-positive chronic hepatitis B patients treated with peginterferon or placebo

    Journal of Medical Virology

    Volume 83, Issue 11, November 2011, Pages: 1917–1923, Bettina E. Hansen, Vincent Rijckborst, Martijn J. ter Borg and Prof. Harry L.A. Janssen

    Article first published online : 13 SEP 2011, DOI: 10.1002/jmv.22208

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22644

  4. Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

    Journal of Medical Virology

    Volume 82, Issue 7, July 2010, Pages: 1135–1142, Bettina E. Hansen, Erik H.C.J. Buster, Ewout W. Steyerberg, Emmanuel Lesaffre and Harry L.A. Janssen

    Article first published online : 25 MAY 2010, DOI: 10.1002/jmv.21778

  5. You have free access to this content
    Abstracts 767 to 1019

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 498A–597A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20926

  6. You have free access to this content
    Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

    Hepatology

    Volume 53, Issue 6, June 2011, Pages: 2121–2129, Yun-Fan Liaw

    Article first published online : 25 MAY 2011, DOI: 10.1002/hep.24364

    Corrected by:

    Correction: Correction: “Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review”

    Vol. 54, Issue 2, 752, Article first published online: 25 JUL 2011

  7. You have free access to this content
    A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

    Hepatology

    Volume 42, Issue 1, July 2005, Pages: 77–85, Vassiliki-Anastasia Sypsa, Konstantinos Mimidis, Nicholas C. Tassopoulos, Dimitrios Chrysagis, Themistoklis Vassiliadis, Antonios Moulakakis, Maria Raptopoulou, Caterina Haida and Angelos Hatzakis

    Article first published online : 16 JUN 2005, DOI: 10.1002/hep.20738

  8. You have free access to this content
    Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1109–1117, William Sievert, Gregory J. Dore, Geoffrey W. McCaughan, Motoko Yoshihara, Darrell H. Crawford, Wendy Cheng, Martin Weltman, William Rawlinson, Bishoy Rizkalla, Jean K. DePamphilis, Stuart K. Roberts and on behalf of the CHARIOT Study Group

    Article first published online : 7 APR 2011, DOI: 10.1002/hep.24180

  9. You have free access to this content
    Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels

    Hepatology

    Volume 58, Issue 3, September 2013, Pages: 872–880, Milan J. Sonneveld, Bettina E. Hansen, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Edward Gane, Yun-Fan Liaw, Qing Xie, E. Jenny Heathcote, Henry L.-Y. Chan and Harry L.A. Janssen

    Article first published online : 29 JUL 2013, DOI: 10.1002/hep.26436

  10. HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism

    Journal of Viral Hepatitis

    Volume 20, Issue 3, March 2013, Pages: 193–199, J. Stenkvist, A. Sönnerborg and O. Weiland

    Article first published online : 20 AUG 2012, DOI: 10.1111/j.1365-2893.2012.01645.x

  11. You have free access to this content
    Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: E1–E9, Yun-Fan Liaw

    Article first published online : 25 JUL 2011, DOI: 10.1002/hep.24473

  12. You have free access to this content
    Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen–positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1251–1257, Milan J. Sonneveld, Vincent Rijckborst, Charles A. B. Boucher, Bettina E. Hansen and Harry L. A. Janssen

    Article first published online : 29 JUL 2010, DOI: 10.1002/hep.23844

  13. Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection

    Journal of Viral Hepatitis

    Volume 21, Issue 1, January 2014, Pages: 42–52, U. Mihm, M.-W. Welker, G. Teuber, H. Wedemeyer, T. Berg, C. Sarrazin, S. Böhm, U. Alshuth, E. Herrmann and S. Zeuzem

    Article first published online : 21 JUN 2013, DOI: 10.1111/jvh.12124

  14. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  15. Hepatitis B surface antigen monitoring and management of chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 18, Issue 7, July 2011, Pages: 449–457, M. J. Sonneveld, R. Zoutendijk and H. L. A. Janssen

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1365-2893.2011.01465.x

  16. Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1512–1522, Willem Pieter Brouwer, Qing Xie, Milan J. Sonneveld, Ningping Zhang, Qin Zhang, Fehmi Tabak, Adrian Streinu-Cercel, Ji-Yao Wang, Ramazan Idilman, Hendrik W. Reesink, Mircea Diculescu, Krzysztof Simon, Mihai Voiculescu, Meral Akdogan, Wlodzimierz Mazur, Jurrien G.P. Reijnders, Elke Verhey, Bettina E. Hansen, Harry L.A. Janssen and for the ARES Study Group

    Article first published online : 27 FEB 2015, DOI: 10.1002/hep.27586

  17. Early viral kinetics on treatment with pegylated interferon-α-2a in chronic hepatitis C virus genotype 1 infection

    Journal of Viral Hepatitis

    Volume 10, Issue 1, January 2003, Pages: 37–42, W. Jessner, R. Stauber, F. Hackl, C. Datz, T. Watkins-Riedel, H. Hofer, A. Gangl, H. Kessler and P. Ferenci

    Article first published online : 28 JAN 2003, DOI: 10.1046/j.1365-2893.2003.00396.x

  18. You have free access to this content
    Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir

    Hepatology

    Volume 53, Issue 5, May 2011, Pages: 1486–1493, Jung Min Lee, Sang Hoon Ahn, Hyon Suk Kim, Hana Park, Hye Young Chang, Do Young Kim, Seong Gyu Hwang, Kyu Sung Rim, Chae Yoon Chon, Kwang-Hyub Han and Jun Yong Park

    Article first published online : 22 APR 2011, DOI: 10.1002/hep.24221

  19. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  20. The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1–infected patients treated with Peg-IFN-alfa-2a and ribavirin

    Journal of Viral Hepatitis

    Volume 19, Issue 7, July 2012, Pages: 488–496, H. Guedj, J. Guedj, F. Negro, M. Lagging, J. Westin, P.-Y. Bochud, S. Bibert, A. U. Neumann and for the DITTO-HCV study group

    Article first published online : 22 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01569.x